This opportunity is no longer accepting applications.
grant RFA-AI-24-023

U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional)

This grant opportunity aims to fund research projects as part of Phase 3 of the U.S.-South Africa Program for Collaborative Biomedical Research. It focuses on HIV/AIDS and related areas such as co-morbidities, co-infections, implementation science, and data science. The program emphasizes building partnerships between researchers in South Africa and the United States to facilitate scientific d…

The purpose of this Notice of Funding Opportunity (NOFO) is to support research projects under Phase 3 of the U.S.-South Africa Program for Collaborative Biomedical Research. Research areas supported under this program include HIV/AIDS, HIV/AIDS co-morbidities and co-infections, HIV/AIDS-associ…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Allergy and Infectious Diseases

Awards & funding

Award Ceiling: $400,000
Award Amount: $400,000

Dates

Opportunity Released: September 17, 2024
Open for Submission: September 17, 2024
Submission Deadline: March 12, 2025
Application Window Closes: March 12, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.